Pedro Valdivielso Selected Research

Homozygous Familial Hypercholesterolemia

1/2019	Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain.
3/2015	[Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro Valdivielso Research Topics

Disease

12	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 04/2010
11	Hypertriglyceridemia 05/2024 - 10/2002
9	Arteriosclerosis 11/2022 - 03/2011
7	Hypertension (High Blood Pressure) 01/2023 - 07/2008
6	Pancreatitis 10/2023 - 06/2009
5	Atherosclerosis 01/2023 - 07/2012
5	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2017
5	Type 2 Diabetes Mellitus (MODY) 10/2014 - 10/2007
4	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 03/2023 - 12/2019
4	Hypercholesterolemia 11/2022 - 08/2002
3	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 03/2023 - 11/2018
3	Obesity 09/2020 - 06/2009
3	Rheumatoid Arthritis 08/2020 - 01/2016
3	Inflammation (Inflammations) 03/2020 - 12/2015
3	Peripheral Arterial Disease 10/2014 - 07/2008
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2022 - 01/2019
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2009
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2021 - 05/2020
2	Costello Syndrome 12/2020 - 11/2018
2	Insulin Resistance 03/2020 - 01/2016
2	Fatty Liver 03/2020 - 05/2017
2	Homozygous Familial Hypercholesterolemia 01/2019 - 03/2015
1	Abdominal Pain (Pain, Abdominal) 10/2023
1	Xanthomatosis (Xanthoma) 10/2023
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 09/2023
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Body Weight (Weight, Body) 05/2021
1	Immunoglobulin G4-Related Disease 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020
1	Testicular Neoplasms (Testicular Cancer) 03/2020
1	Prediabetic State (Prediabetes) 07/2019
1	Chronic Renal Insufficiency 01/2019
1	Vascular Calcification 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Arterial calcification of infancy 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2014
1	Vascular Diseases (Vascular Disease) 10/2007
1	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2003

Drug/Important Bio-Agent (IBA)

20	LipidsIBA 05/2024 - 10/2007
13	Triglycerides (Triacylglycerol)IBA 05/2024 - 10/2007
7	LDL CholesterolIBA 05/2024 - 07/2008
6	Lipoproteins (Lipoprotein)IBA 09/2023 - 01/2009
5	HDL CholesterolIBA 05/2024 - 07/2008
5	ApolipoproteinsIBA 01/2022 - 02/2012
4	Apolipoprotein B-48IBA 01/2022 - 01/2009
3	diphosphoric acid (pyrophosphoric acid)IBA 03/2023 - 01/2018
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2023 - 06/2009
3	CholesterolIBA 11/2021 - 05/2019
3	oxidized low density lipoproteinIBA 11/2021 - 03/2015
3	Apolipoproteins E (ApoE)IBA 02/2012 - 06/2009
2	Alkaline PhosphataseIBA 03/2023 - 12/2019
2	CytokinesIBA 01/2022 - 01/2016
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2021 - 01/2009
2	ChylomicronsIBA 12/2020 - 12/2015
2	EnzymesIBA 12/2019 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 07/2019 - 04/2010
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2019 - 07/2008
2	Apolipoprotein C-II (ApoC2)IBA 11/2018 - 06/2009
2	Lipase (Acid Lipase)FDA Link 06/2009 - 07/2008
2	Atorvastatin (Lipitor)FDA Link 04/2003 - 08/2002
1	Lansoprazole (Prevacid)FDA LinkGeneric 03/2023
1	CreatinineIBA 01/2023
1	C-Reactive ProteinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	SugarsIBA 05/2021
1	Fibric Acids (Fibrates)IBA 05/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	VLDL LipoproteinsIBA 12/2020
1	Apolipoproteins B (ApoB)IBA 12/2020
1	ElastinIBA 05/2020
1	CalciumIBA 03/2020
1	HDL LipoproteinsIBA 03/2020
1	PCSK9 InhibitorsIBA 05/2019
1	Phosphorus (Red Phosphorus)IBA 01/2019
1	Apolipoprotein B-100 (Apo B 100)IBA 01/2019
1	Proprotein Convertase 9IBA 01/2019
1	Apolipoprotein A-VIBA 11/2018
1	Chylomicron RemnantsIBA 02/2018
1	A-factor (Streptomyces)IBA 01/2018
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Olive OilIBA 05/2017
1	AdipokinesIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 09/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2012
1	Fluvastatin FDA Link 01/2009
1	Fenofibrate (CiL)FDA LinkGeneric 10/2002

Therapy/Procedure

6	Therapeutics 01/2023 - 08/2002
3	Secondary Prevention 11/2022 - 11/2018
2	Drug Therapy (Chemotherapy) 03/2020 - 06/2009
2	Mediterranean Diet 07/2017 - 05/2017
1	Bariatric Surgery 01/2022
1	Caloric Restriction 05/2021
1	Radiotherapy 03/2020
1	Tertiary Prevention 09/2015
1	Denervation 12/2012